255 related articles for article (PubMed ID: 6327850)
1. Effect of combined acyclovir and vidarabine on infection with herpes simplex virus in vitro and in vivo.
Park NH; Callahan JG; Pavan-Langston D
J Infect Dis; 1984 May; 149(5):757-62. PubMed ID: 6327850
[TBL] [Abstract][Full Text] [Related]
2. Effects of 2,2'-O-cyclocytidine and acyclovir on latent herpes simplex virus in trigeminal ganglia of mice.
Liu WG; Chen ZJ; Song JZ; Ma ZX
Antimicrob Agents Chemother; 1986 Feb; 29(2):278-80. PubMed ID: 2424367
[TBL] [Abstract][Full Text] [Related]
3. Progressive mucocutaneous herpes simplex infection due to acyclovir-resistant virus in an immunocompromised patient: correlation of viral susceptibilities and plasma levels with response to therapy.
Bean B; Fletcher C; Englund J; Lehrman SN; Ellis MN
Diagn Microbiol Infect Dis; 1987 Jul; 7(3):199-204. PubMed ID: 2820649
[TBL] [Abstract][Full Text] [Related]
4. Limited efficacy of inhibitors of herpes simplex virus DNA synthesis in murine models of recrudescent disease.
Kristofferson A; Ericson AC; Sohl-Akerlund A; Datema R
J Gen Virol; 1988 Jun; 69 ( Pt 6)():1157-66. PubMed ID: 2838569
[TBL] [Abstract][Full Text] [Related]
5. Effect of combinations of acyclovir with vidarabine or its 5'-monophosphate on herpes simplex viruses in cell culture and in mice.
Schinazi RF; Peters J; Williams CC; Chance D; Nahmias AJ
Antimicrob Agents Chemother; 1982 Sep; 22(3):499-507. PubMed ID: 6182836
[TBL] [Abstract][Full Text] [Related]
6. [Resistance of herpes simplex viruses to antiviral drugs].
Scieux C; Bianchi A
Pathol Biol (Paris); 1993 Feb; 41(2):172-7. PubMed ID: 8392160
[TBL] [Abstract][Full Text] [Related]
7. Effect of acyclovir, bromovinyldeoxyuridine, vidarabine, and L-lysine on latent ganglionic herpes simplex virus in vitro.
Park NH; Pavan-Langston D; Declercq E
Am J Med; 1982 Jul; 73(1A):151-4. PubMed ID: 6285706
[TBL] [Abstract][Full Text] [Related]
8. Persistent reactivable latent herpes simplex virus infection in trigeminal ganglia of mice treated with antiviral drugs.
Svennerholm B; Vahlne A; Lycke E
Arch Virol; 1981; 69(1):43-8. PubMed ID: 6271097
[TBL] [Abstract][Full Text] [Related]
9. Effect of acyclovir on latent herpes simplex virus infections in trigeminal ganglia of mice.
Klein RJ; DeStefano E; Friedman-Kien AE; Brady E
Antimicrob Agents Chemother; 1981 May; 19(5):937-9. PubMed ID: 6271054
[TBL] [Abstract][Full Text] [Related]
10. A controlled trial comparing vidarabine with acyclovir in neonatal herpes simplex virus infection. Infectious Diseases Collaborative Antiviral Study Group.
Whitley R; Arvin A; Prober C; Burchett S; Corey L; Powell D; Plotkin S; Starr S; Alford C; Connor J
N Engl J Med; 1991 Feb; 324(7):444-9. PubMed ID: 1988829
[TBL] [Abstract][Full Text] [Related]
11. Synergistic antiviral effects of acyclovir and vidarabine on herpes simplex infection in newborn mice.
Karim MR; Marks MI; Benton DC; Rollerson W
Chemotherapy; 1985; 31(4):310-7. PubMed ID: 4028874
[TBL] [Abstract][Full Text] [Related]
12. Beta interferon plus gamma interferon efficiently reduces acyclovir-resistant herpes simplex virus infection in mice in a T-cell-independent manner.
Huang WY; Su YH; Yao HW; Ling P; Tung YY; Chen SH; Wang X; Chen SH
J Gen Virol; 2010 Mar; 91(Pt 3):591-8. PubMed ID: 19906941
[TBL] [Abstract][Full Text] [Related]
13. Acylovir in oral and ganglionic herpes simplex virus infections.
Park NH; Pavan-Langston D; McLean SL
J Infect Dis; 1979 Nov; 140(5):802-6. PubMed ID: 316819
[TBL] [Abstract][Full Text] [Related]
14. Acyclovir treatment of disseminated herpes simplex virus type 2 infection in weanling mice: alteration of mortality and pathogenesis.
Kern ER; Richards JT; Overall JC
Antiviral Res; 1986 Jul; 6(4):189-95. PubMed ID: 2427021
[TBL] [Abstract][Full Text] [Related]
15. Novel animal model for evaluating topical efficacy of antiviral agents: flux versus efficacy correlations in the acyclovir treatment of cutaneous herpes simplex virus type 1 (HSV-1) infections in hairless mice.
Lee PH; Su MH; Kern ER; Higuchi WI
Pharm Res; 1992 Aug; 9(8):979-89. PubMed ID: 1329068
[TBL] [Abstract][Full Text] [Related]
16. Acyclovir blocks cytokine gene expression in trigeminal ganglia latently infected with herpes simplex virus type 1.
Halford WP; Gebhardt BM; Carr DJ
Virology; 1997 Nov; 238(1):53-63. PubMed ID: 9375008
[TBL] [Abstract][Full Text] [Related]
17. Vidarabine versus acyclovir therapy in herpes simplex encephalitis.
Whitley RJ; Alford CA; Hirsch MS; Schooley RT; Luby JP; Aoki FY; Hanley D; Nahmias AJ; Soong SJ
N Engl J Med; 1986 Jan; 314(3):144-9. PubMed ID: 3001520
[TBL] [Abstract][Full Text] [Related]
18. Combination chemotherapy: interaction of 5-methoxymethyldeoxyuridine with trifluorothymidine, phosphonoformate and acycloguanosine against herpes simplex viruses.
Ayisi NK; Gupta SV; Babiuk LA
Antiviral Res; 1985 Feb; 5(1):13-27. PubMed ID: 2984988
[TBL] [Abstract][Full Text] [Related]
19. Foscarnet therapy for acyclovir-resistant mucocutaneous herpes simplex virus infection in 26 AIDS patients: preliminary data.
Safrin S; Assaykeen T; Follansbee S; Mills J
J Infect Dis; 1990 Jun; 161(6):1078-84. PubMed ID: 2161035
[TBL] [Abstract][Full Text] [Related]
20. Enhanced efficacy of nucleoside analogs and recombinant alpha interferon in weanling mice lethally infected with herpes simplex virus type 2.
Crane LR; Sunstrum JC
Antiviral Res; 1988; 9(1-2):1-9. PubMed ID: 2455473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
